Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials

By afschroeder • September 9, 2026

Hageen AW, Gadelmawla AF, Saleh AO, Bahnasy S, Eladawi S, Abdelaziz M, Iyad K, Kandil AH, Zinhom K, Mohamed MR, Abdulhay H, Turkman M, Abdelazeem B, Fonarow GC. Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials. Endocrinol Diabetes Metab. 2026 Sep;9(5):e70313. doi: 10.1002/edm2.70313. PMID: 42706739; PMCID: PMC13550879.

Tags: Cardiology/Epi, cardiometabolic outcomes, dulaglutide, Publications, RCTs, tirzepatide, Type 2 diabetes mellitus

Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension

Alotaibi M, Tang A, Sun N, Gurholt I, Yuguchi E, Roberts K, Preston I, Warburton R, Yuan JX, Kim NH, Chan SY, Jain M, Cheng[...]

Artificial intelligence-enabled electrocardiography for detection of left ventricular diastolic dysfunction: a systematic review and meta-analysis

Edjimbi J, Shah N, Donisi L, Gajjar A, See C, Grimshaw AA, Diop HB, Ribeiro ALP, Marijon E, Clifford G, Gaye B. Artificial intelligence-enabled electrocardiography[...]

Heart failure among people with HIV: prescription of guideline-directed medical therapy

Cutshaw MK, Clare R, Chiswell K, Hofmann P, Pettit AC, Meissner E, Durstenfeld MS, Longenecker CT, Bloomfield GS, Okeke NL. Heart failure among people with[...]